Part 2 knowing undercover-employee placement restriction

Editorial approval scope: The team checked current source fidelity, scope boundaries, dates, arithmetic, reader usefulness, practical workflow, and general-information limitations.

Current rule checkpoint

Live 42 CFR 2.17(a) bars a Part 2 program from knowingly employing an undercover agent or informant unless a court order under 42 CFR 2.67 specifically authorizes the placement. Section 2.17(b) separately bars use or disclosure of information obtained by an undercover agent or informant to criminally investigate or prosecute any patient. The HHS fact sheet identifies February 16, 2026 as the compliance date for the amended framework.

Knowing placement is the trigger

Current 42 CFR 2.17 applies when the program knowingly employs an undercover agent or informant. Escalate a disclosed government request, credential, court filing, unusual placement instruction, or other credible evidence to the authorized legal and privacy response team.

A court order has a specific scope

The § 2.67 route concerns investigation of program employees or agents for suspected criminal activity. It has application, notice, good-cause, content, duration, confidentiality, disruption, and patient-use limits. A subpoena or informal request is a different artifact.

Preserve normal workforce controls

Verify identity and qualifications through lawful processes, restrict access to assigned duties, use unique credentials, log activity, protect patients, preserve evidence, and route suspected misconduct under counsel. Avoid tipping off a placement when a valid order and law require confidentiality.

Escalate credible placement information without creating a private investigation

Train designated leaders to recognize a disclosed agency request, court application or order, government contact, instruction to conceal an identity, or other specific evidence of an undercover or informant placement. Route it immediately to experienced Part 2 counsel, privacy, security, and the authorized program leader.

Do not search ordinary applicants' private lives, impose stigmatizing screening, or treat unusual behavior, background, government service, journalism, patient advocacy, or whistleblowing as proof. Keep normal employment, discrimination, labor, credentialing, and privacy rules in place.

Authenticate the court order and permitted placement

Verify court, case, judge, signature, date, seal, investigative agency, program, employee or agent investigation, placement type, start, end, authorized contacts, confidentiality, and later modifications through trusted channels. Section 2.67 requires a specific placement order based on good cause; a subpoena, warrant, agency letter, prosecutor request, or general investigative order is not the same artifact.

Record whether the program director received notice and an opportunity to be heard or the application asserted a regulatory reason for withholding that notice. Counsel should control any court response and prevent unauthorized internal circulation.

Implement the order's limits

Section 2.67 limits an ordered placement to twelve months from on-site placement unless a new order extends it. The order must address patient-information limits and measures to reduce disruption and confidentiality harm. Build an order matrix for role, location, systems, data, action, purpose, contacts, period, reporting, and prohibited use.

Use unique credentials, least access consistent with the order and assigned role, monitoring, secure communication, and a restricted decision file. Keep treatment teams clinically independent. Do not expose unrelated patient records or alter ordinary controls merely to make investigation easier.

Protect patients and preserve the use boundary

Information from the placement cannot be used or disclosed to criminally investigate or prosecute a patient. Identify and segregate patient information, prevent it from entering unrelated investigative files, and preserve the order's restrictions in exports, notes, testimony, agency transfers, and downstream systems.

Escalate any request to use patient information, broaden access, extend time, change role, or investigate a different target. Do not rely on an informal agency assurance when the order or rule does not support the change.

Close the placement deliberately

Track the on-site start, twelve-month limit, extensions, role changes, credentials, devices, records, reports, and end conditions. At closure, remove access, recover assets, preserve required evidence, verify patient information disposition, review logs, document incidents, and remediate program disruption or confidentiality exposure.

Limit who learns the placement even after it ends, consistent with law and counsel direction. Review lessons without identifying patients or compromising a continuing matter.

Example

Nine unusual placement requests reach legal review. Seven have requester identity, authority, order status, scope, role, access plan, confidentiality controls, owner, and closure evidence; two rely on an agency email. Readiness is 7 of 9 requests.

Undercover-employee checklist

• distinguish credible placement evidence from ordinary employment or personal characteristics;
• authenticate a section 2.67 order, court, agency, scope, dates, and modifications;
• map role, system, data, action, purpose, contacts, time, and prohibited use;
• preserve ordinary security and clinical independence while limiting internal awareness;
• prevent all patient criminal-investigation or prosecution use and disclosure; and
• end access, recover assets, reconcile information, review incidents, and document closure.

This is a specialized court-order process. The program should use experienced Part 2 counsel rather than negotiating an undercover placement through routine human-resources or agency channels.